Worldwide median pharmaceutical M&A value to revenue multiple 2011-2015
This statistic shows the median merger and acquisition (M&A) value to revenue multiple for generic pharmaceutical M&A deals worldwide from 2011 to 2015. In 2015, the median M&A value to revenue multiple was 5.1, almost double what it was in 2011.